A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: A phase 3 open randomised controlled trial

Archives of Disease in Childhood

Volumn 93, Issue 11, 2008, Pages 963-970

  Pace, David ^a   Snape, M ^a   Westcar, S ^a   Oluwalana, C ^a   Yu, L M ^a   Begg, N ^b   Wysocki, J ^c,d   Czajka, H ^e   Maechler, G ^b   Boutriau, D ^b   Pollard, A J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d Dispensary Medicine of Development Age   (Poland)

^e Cracow University Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; GLYCOCONJUGATE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMAGGLUTININ; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; TETANUS TOXOID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; INFLUENZA; MEASLES; MUMPS; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RUBELLA;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; FEMALE; GREAT BRITAIN; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS, SEROGROUP C; POLAND; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 55349145646     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.136036     Document Type: Article

References (28)

1. Miller E, Salisbury D, Ramsay ME. Planning, registration and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 2001;20(Suppl 1):S58-67.
2. Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002;86:396-9.
3. Heath PT, Booy R, Azzopardi HJ, et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 2000;284:2334-40.
4. McVernon J, Andrews N, Slack MP, et al. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003;361:1521-3.
5. Borrow R, Goldblatt D, Andrews N, et al. Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom. J Infect Dis 2002;186:1353-7.
6. Snape MD, Kelly DF, Green B, et al. Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine. Pediatr Infect Dis J 2005;24:128-31.
7. Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004;364:365-7.
8. Anderson P, Ingram DL, Pichichero ME, et al. A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis. Pediatr Infect Dis J 2000;19:589-91.
9. Auckland C, Gray S, Borrow R, et al. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J Infect Dis 2006;194:1745-52.
10. Donaldson L, Beasley C, Ridge K. Important changes to the childhood immunisation programme. Department of Health. Available at http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/ Professionalletters/Chiefmedicalofficerletters/DH_4137171 (accessed 2 July 2008).
11. Pace D, Snape MD, Westcar S, et al. Immunogenicity, safety and reactogenicity of a combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in infants. Pediatr Infect Dis J 2007;26:1057-9.
12. Brunell PA, Brickman A, Steinberg S. Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response. Am J Dis Child 1969;118:435-40.
13. Andrews N, Borrow R, Miller E. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin Diagn Lab Immunol 2003;10:780-6.
14. Amato Neto V, Finger H, Gotschlich EC, et al. Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children. Rev Inst Med Trop Sao Paulo 1974;16:149-53.
15. Kayhty H, Peltola H, Karanko V, et al. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
16. Wharton M, Vitek CR. Diphtheria toxoid. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: WB Saunders, 2003:211-18.
17. Wassilak SGF, Roper MH, Murphy TV, et al. Tetanus toxoid. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: WB Saunders, 2003:745-81
18. World Health Organization. Standard procedures for determining immunity to poliovirus using the micro-neutralization test. WHO/EPI/GEN 93.9. Geneva, Switzerland: World Health Organization, 1993.
19. Kelly DF, Pollard AJ, Moxon ER. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 2005;294:3019-23.
20. Eskola J, Ward J, Dagan R, et al. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999;354:2063-8.
21. Schmitt HJ, Maechler G, Habermehl P, et al. Immunogenicity, reactogenicity and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine. Clin Vaccine Immunol 2007;14:426-34.
22. Kelly DF, Snape MD, Clutterbuck EA, et al. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 2006;108:2642-7.
23. Granoff DM, Pollard AJ. Reconsideration of the use of meningococcal polysaccharide vaccine. Pediatr Infect Dis J 2007;26:716-22.
24. Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann N Y Acad Sci 1995;754:35-47.
25. Richmond P, Borrow R, Goldblatt D, et al. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis 2001;183:160-3.
26. Borrow R, Balmer P, Miller E. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 2005;23:2222-7.
27. Tinnion ON, Hanlon M. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 1999;(2):CD001478.
28. Nolan T, Lambert S, Roberton D, et al. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine 2007;25:8487-99.